• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Raymond James Financial Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    5/21/25 4:36:31 PM ET
    $RJF
    Investment Bankers/Brokers/Service
    Finance
    Get the next $RJF alert in real time by email
    rjf-20250521
    0000720005false00007200052025-05-212025-05-210000720005us-gaap:CommonStockMember2025-05-212025-05-210000720005rjf:DepositarySharesSeriesBMember2025-05-212025-05-21



    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C.  20549

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    May 21, 2025
    Date of Report (date of earliest event reported)

    RAYMOND JAMES FINANCIAL, INC.
    (Exact name of registrant as specified in its charter)

    Florida
    1-9109
    59-1517485
    (State or other jurisdiction of incorporation)
    (Commission File Number)
    (I.R.S. Employer Identification No.)
    880 Carillon Parkway
    St. Petersburg
    Florida
    33716
    (Address of principal executive offices)
    (Zip Code)

    (727) 567-1000
    (Registrant’s telephone number, including area code)

    None
    (Former name or former address, if changed since last report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Exchange Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Stock, $.01 par valueRJFNew York Stock Exchange
    Depositary Shares, Each Representing a 1/40th Interest in a Share of 6.375% Fixed-to-Floating Rate Series B Non-Cumulative Perpetual Preferred StockRJF PrBNew York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act (17 CFR 230.405) or Rule 12b-2 of the Exchange Act (17 CFR 240.12b-2).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
    ☐



    Item 7.01 Regulation FD Disclosure

    On May 21, 2025, Raymond James Financial, Inc. (the “Company”) issued a press release to disclose its operating data for April 2025. A copy of this press release is attached to this Current Report as Exhibit 99.1 and is incorporated herein by reference.

    The information in this Current Report, including any exhibits hereto, is being “furnished” and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company with the Securities and Exchange Commission, whether made before or after the date hereof, regardless of any general incorporation language in such filings (unless the Company specifically states that the information or exhibit in this particular report is incorporated by reference).

    Item 9.01 Financial Statements and Exhibits

    (d) Exhibits. The following are filed as exhibits to this report:

    Exhibit No.

    99.1 Press release, dated May 21, 2025, issued by Raymond James Financial, Inc.
    104 Cover Page Interactive Data File (embedded within the Inline XBRL document).


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    RAYMOND JAMES FINANCIAL, INC.
    Date: May 21, 2025
    By:
      /s/ Jonathan W. Oorlog, Jr.
    Jonathan W. Oorlog, Jr.
    Chief Financial Officer



    Get the next $RJF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RJF

    DatePrice TargetRatingAnalyst
    4/30/2025$159.00Buy → Neutral
    BofA Securities
    1/7/2025$151.00 → $166.00Overweight → Neutral
    Analyst
    1/6/2025$161.00 → $185.00Neutral → Buy
    Goldman
    12/12/2024$152.00 → $169.00Overweight → Equal Weight
    Wells Fargo
    10/9/2024$146.00Mkt Perform → Mkt Outperform
    JMP Securities
    9/12/2024$138.00Overweight
    Wells Fargo
    7/8/2024Outperform → Peer Perform
    Wolfe Research
    1/10/2024$110.00 → $135.00Neutral → Overweight
    JP Morgan
    More analyst ratings